Biocompatible coatings, and methods of making and using the same
View Patent ↗Disclosed herein are biocompatible coatings for a substrate, the biocompatible coating including at least one polyanionic/polycationic bilayer including at least one nitric oxide generating moiety, wherein the polyanionic/polycationic bilayer has a layer of a polycationic polymeric material; and a layer of polyanionic material capable of non-covalently bonding to the polycationic polymeric material. Devices incorporating such coatings, and methods of making and using such coatings are also disclosed herein.
1. A biocompatible coating for a substrate, the biocompatible coating comprising multiple polyanionic/polycationic bilayers comprising at least one organoselenium moiety, wherein each of the polyanionic/polycationic bilayers comprises:
a layer of a polycationic polymeric material having the at least one organoselenium moiety covalently bonded thereto; and
a layer of polyanionic material capable of non-covalently bonding to the polycationic polymeric material.
2. The biocompatible coating of claim 1 , wherein the polycationic polymeric material comprises at least one of: polyethyleneimine, chitosan, or quaternized polyamide.
3. The biocompatible coating of claim 1 , wherein the polyanionic material comprises at least one of: sodium alginate, cellulose sulfate, polyglutamic acid, heparin, or hyaluronic acid.
4. The biocompatible coating of claim 1 , wherein the polycationic polymeric material comprises polyethyleneimine.
5. The biocompatible coating of claim 1 , wherein the polyanionic material comprises sodium alginate.
6. The biocompatible coating of claim 1 , wherein the substrate comprises at least one of a polymer or a biomedically acceptable metal.
7. The biocompatible coating of claim 1 , wherein the substrate comprises polyurethane or silicone.
8. The biocompatible coating of claim 1 , wherein the organoselenium moiety is selected from the group consisting of selenocystamine, selenocystine, 3,3′-diselenodipropionic acid, selenocysteine, ebselen, propyl-selenocystine, allyl-selenocystine, methyl-selenocystine, selenomethionine, selenium choline, and a diselenium compound.
9. The biocompatible coating of claim 1 , wherein the organoselenium moiety is 3,3′-diselenodipropionic acid.
10. The biocompatible coating of claim 1 , wherein the biocompatible coating comprises at least four polyanionic/polycationic bilayers.
11. The biocompatible coating of claim 1 , wherein the biocompatible coating comprises at least ten polyanionic/polycationic bilayers.
12. The biocompatible coating of claim 1 , comprising about 1 μg/cm 2 to about 4 μg/cm 2 Se when the coating is placed on the substrate.
13. The biocompatible coating of claim 1 , wherein a maximum NO flux ranges from about 1 mol/(cm 2 )(min) to about 10 mol/(cm 2 )(min) when the coating at least partially coats the substrate and the substrate is placed in contact with blood.
14. A medical device comprising the biocompatible coating of claim 1 .
15. The medical device of claim 14 , wherein the medical device is selected from the group consisting of an intravascular or extravascular medical device, a balloon, a catheter tip, a prosthetic heart valve, a suture, a surgical staple, a synthetic vessel graft, a stent, a stent graft, a vascular or non-vascular graft, a shunt, an aneurysm filler, an intraluminal paving system, a guide wire, an embolic agent, a filter, a drug pump, an arteriovenous shunt, an artificial heart valve, an artificial implant, a foreign body introduced surgically into the blood vessels or at a vascular or non-vascular site, a lead, a pacemaker, an implantable pulse generator, an implantable cardiac defibrillator, a cardioverter defibrillator, a defibrillator, a spinal stimulator, a brain stimulator, a sacral nerve stimulator, a chemical sensor, an implantable chemical sensor, an interventional cardiology device, a catheter, and plastic tubing.
16. A method of forming a polymeric coating on a substrate capable of generating nitric oxide in-vivo, comprising:
a) providing a substrate;
b) immersing the substrate into a first solution comprising a polycationic polymer covalently bonded to an organoselenium moiety;
c) immersing the substrate into a second solution comprising a polyanionic polymer; and
d) repeating b) and c).
17. The method of claim 16 , further comprising immersing the substrate in an annealing solution comprising:
glutathione or S-nitrosoglutathione; and
phosphate buffered saline.
18. The method of claim 17 , wherein the substrate is immersed in the annealing solution for at least one day.